# Subcutaneous Injections of ASC to Heal Digital Ulcers in Patients With Scleroderma.

> **NCT04356755** · PHASE2 · RECRUITING · sponsor: **University Hospital, Toulouse** · enrollment: 32 (estimated)

## Conditions studied

- Systemic Sclerosis

## Interventions

- **DRUG:** AdMSC
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT04356755
- **Lead sponsor:** University Hospital, Toulouse
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2020-09-22
- **Primary completion:** 2027-03
- **Final completion:** 2027-03
- **Target enrollment:** 32 (ESTIMATED)
- **Last updated:** 2025-12-31


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04356755

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04356755, "Subcutaneous Injections of ASC to Heal Digital Ulcers in Patients With Scleroderma.". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT04356755. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*